For more than four decades, researchers tracked the coffee and tea habits of roughly 130,000 American health professionals and nurses. By the time they tallied the results, 11,033 participants had been diagnosed with dementia. The people who consistently drank about 2 to 3 cups of coffee or tea per day had a 35 percent lower risk of developing the disease compared with those who drank little or none.
The findings, published in JAMA Internal Medicine by a team led by Yuan Zhang of Shandong University and Harvard T.H. Chan School of Public Health, represent one of the longest dietary studies ever conducted on coffee and brain health. They also come with a critical caveat: the study is observational, meaning it cannot prove that coffee itself prevented a single case of dementia.
What the study actually measured
The analysis pooled data from three well-established Harvard-based cohorts: the Nurses’ Health Study (launched in 1976), the Nurses’ Health Study II (1989), and the Health Professionals Follow-up Study (1986). Participants reported their diets every two to four years using a semiquantitative food frequency questionnaire originally validated by Walter Willett and colleagues at Harvard. For the Health Professionals Follow-up Study, an expanded version of the same instrument was validated separately by Rimm et al. in a 1992 study published in the American Journal of Epidemiology, which found very high reproducibility for coffee intake specifically. That level of measurement consistency means the coffee data feeding the dementia analysis was not based on a single, error-prone snapshot but on tools refined over years.
This repeated measurement matters. Rather than asking people once what they drank and assuming the answer held true for 40 years, the researchers captured shifting habits over time. Someone who quit coffee in their 50s or picked it up in their 60s would show up differently than a lifelong three-cup-a-day drinker. That granularity gives the intake data a sturdier foundation than a single baseline snapshot would.
Dementia diagnoses were identified through medical records, Medicare claims data, and the National Death Index rather than self-report, reducing the chance of misclassification. Over an average follow-up of roughly 37 years, the researchers found a clear dose-response pattern: risk declined as intake rose from zero to about 2.5 cups per day, then leveled off. The strongest association clustered around that 2-to-3-cup range.
Why the 35% number is not as simple as it sounds
A 35 percent reduction in relative risk is a striking figure, but it does not mean that drinking coffee will cut any individual’s chance of dementia by a third. Observational studies, regardless of size or duration, cannot rule out the possibility that moderate coffee drinkers differ from non-drinkers in ways that independently protect the brain. They may exercise more, eat better, have higher incomes, or carry different genetic profiles. The researchers adjusted for age, sex, smoking, alcohol, body mass index, physical activity, diet quality, and several chronic conditions, but unmeasured confounders could still account for part of the effect.
Harvard Health’s own commentary on the study explicitly urged readers not to interpret the association as proof that coffee prevents dementia. That kind of caution from the researchers’ home institution is worth taking seriously.
There is also the question of who was studied. The three cohorts consisted overwhelmingly of white, educated health professionals in the United States. Whether the same pattern holds across different racial, ethnic, and socioeconomic groups remains an open question.
Supporting evidence from a separate population
The Harvard findings do not exist in isolation. A 2021 study using the UK Biobank, published in PLOS Medicine, examined coffee and tea consumption alongside stroke and poststroke dementia in more than 365,000 British adults. That analysis found broadly similar dose-response curves: moderate intake of coffee, tea, or both was associated with lower risks of stroke and dementia, even after adjusting for a wide range of lifestyle and health variables.
Seeing comparable patterns in an independent population with different dietary norms and a different healthcare system strengthens the signal. But replication of an observational association is not the same as proving causation. It simply means the pattern is consistent enough to warrant deeper investigation.
What might explain the link biologically
Caffeine crosses the blood-brain barrier and has shown neuroprotective effects in animal studies, including reduced accumulation of amyloid-beta, the protein that clumps in the brains of Alzheimer’s patients. Coffee and tea also contain polyphenols, compounds with antioxidant and anti-inflammatory properties that may help protect blood vessels in the brain.
These are plausible mechanisms, not proven ones. No randomized controlled trial in humans has demonstrated that adding coffee to a person’s routine lowers dementia incidence. Animal models and lab studies can suggest pathways, but they cannot confirm that those pathways operate meaningfully in a living human brain over decades of aging.
Practical questions the study does not answer
Readers will reasonably wonder about details the study was not designed to address. A standard “cup” in these cohorts was defined as 8 ounces of brewed coffee, not a 16-ounce latte loaded with flavored syrup. The analysis did not distinguish between filtered and unfiltered brewing methods, which differ in their chemical profiles. It also did not separate caffeinated from decaffeinated coffee in its primary findings, so whether caffeine itself is the active ingredient or simply a marker for other compounds in coffee remains unclear.
People who metabolize caffeine slowly due to variants in the CYP1A2 gene may respond differently to the same number of cups, and the study did not stratify by genetic caffeine metabolism. For individuals with conditions affected by caffeine, including certain cardiac arrhythmias, generalized anxiety disorder, or pregnancy, existing medical guidance should take priority over any potential cognitive benefit.
Where this fits in the bigger picture of brain health
No major medical organization currently recommends starting coffee specifically to prevent dementia. The Alzheimer’s Association, the World Health Organization, and the American Heart Association all emphasize physical activity, blood pressure management, not smoking, social engagement, and cognitive stimulation as the strongest evidence-based strategies for reducing dementia risk.
Coffee may eventually earn a place on that list, but as of June 2026, the evidence supports a more modest conclusion: moderate coffee or tea consumption appears compatible with healthy brain aging and is associated with lower dementia risk in large observational studies. For the millions of people who already drink 2 to 3 cups a day, that is reassuring. For those who do not, it is not yet a reason to start.
What researchers are likely to test next
The next steps researchers are likely to pursue include mechanistic studies incorporating genetic and metabolic biomarkers, more diverse cohort analyses, and eventually randomized trials testing whether changing coffee intake alters intermediate markers of brain health such as cerebral blood flow or neuroinflammation. Until that work is done, coffee remains a promising but unproven piece of the dementia prevention puzzle.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
